Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Dow's steep stock decline has boosted its dividend yield significantly. LyondellBasell's yield isn't too far behind Dow's, ...

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $ ...

In summary, income-focused investors may find Pfizer stock an attractive option for making a steady income of $100 per month ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

Pfizer's Q4 2024 results were higher than anticipated, with resilience in its underlying pharmaceutical business despite the headwind presented by the drop in COVID-19 revenue. The company ...

Pfizer (NYSE:PFE) is scheduled to announce Q4 earnings results on Tuesday, February 4th, before market open. Analysts expect ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers. The branded ...

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...